CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 59 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,625,000 | -31.2% | 74,288 | +0.3% | 0.00% | -40.0% |
| Q2 2023 | $2,361,000 | +30.6% | 74,038 | -0.7% | 0.01% | +25.0% |
| Q1 2023 | $1,808,000 | -23.9% | 74,538 | -0.7% | 0.00% | -20.0% |
| Q4 2022 | $2,375,000 | +12.1% | 75,038 | -0.0% | 0.01% | -16.7% |
| Q3 2022 | $2,118,000 | +6.2% | 75,068 | -0.7% | 0.01% | +20.0% |
| Q2 2022 | $1,994,000 | -25.8% | 75,568 | -0.8% | 0.01% | -16.7% |
| Q1 2022 | $2,689,000 | +13.4% | 76,168 | +3.6% | 0.01% | +20.0% |
| Q4 2021 | $2,371,000 | +11.1% | 73,488 | +2.3% | 0.01% | -16.7% |
| Q3 2021 | $2,134,000 | +15.4% | 71,844 | 0.0% | 0.01% | +20.0% |
| Q2 2021 | $1,850,000 | +102.4% | 71,844 | +8.0% | 0.01% | +66.7% |
| Q1 2021 | $914,000 | +21.5% | 66,544 | +46.8% | 0.00% | 0.0% |
| Q4 2020 | $752,000 | – | 45,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anchor Investment Management, LLC | 100 | $4,240 | 0.00% |